Introduction
Peripheral nerve injuries (PNI) are common and have marked impact on the everyday life of the population at large. Thirty percent of these injuries arise from lacerations by sharp objects and long bone fractures, 1 and in the remaining penetrating injuries, crush, ischemia, traction, electric shock and vibration play a role. 2 Approximately 100 000 patients undergo peripheral nerve surgery in the USA and Europe annually.
The primary goal of nerve repair is to allow reinnervation of the target organs by guiding regenerating sensory, motor and autonomic axons into the environment of the distal nerve with minimal loss of fibers at the site of repair. 4 Many factors have to be taken into consideration when trying to predict the outcome of peripheral nerve repair, including type, location and extent of nerve injury; timing of surgery; type of repair; proper alignment of fascicles; surgical technique and patient comorbidities. 5 In the last century, much has been learnt of peripheral nerve pathophysiology. 6 The introduction of microsurgical nerve repair has been a breakthrough. 7 Nerve allografting made it possible to bridge large nerve defects, 8 which was previously unachievable with application of standard autografting methods. 8 Tubularization techniques can eliminate the morbidity of autograft harvesting, and provide comparable outcomes in short nerve gap repair. 9 However, despite meticulous surgical techniques and different repair methods, fully functional outcome, especially of motor function, is rarely achieved. 10 Non-surgical approaches have been developed to enhance nerve recovery. 11, 12 These are complementary to surgery, and are an adjunct to the reinnervation process. 13, 14 We review the literature on experimental non-surgical approaches for PNI recovery in human, animals and in vitro studies.
Material and methods
A search of PubMed, Medline, CINAHL and Embase databases was performed using the following keywords 'peripheral nerve injury' and 'treatment' on the 1 January 2011.
Scientific articles reporting in vitro, animal and human studies were suitable if detailing a non-surgical, conservative or adjuvant therapy in a peripheral nerve injury. Their bibliographies were thoroughly reviewed by hand to identify further related articles. To be included, the study had to be a prospective clinical study, a randomized controlled trial, a non-randomized clinical trial or a prospective case series. There had to be a well-described intervention in the form of application, the treatment, the source, the hypothesis, the method of administration and the target cellule or nerve. The outcomes had to be reported in terms of (i) molecular changes, myelination or nerve regeneration in vitro studies, (ii) histological changes, electrophysiological reinnervation or functional outcomes in animal studies, and (iii) time of nerve regeneration, motor or sensory function.
We thus identified 54 of 479 studies which investigated the use of nonsurgical treatments in PNI (Fig. 1) . 15 -31 Of the 54 studies, 11 were undertaken in vitro, 39 in animal models and 4 in humans (Tables 1-3) .
Exclusion criteria
Studies in language other than English, French, Italian, Spanish and Portuguese, pain therapies, spinal cord injuries and results published as abstracts only were excluded from the present study.
In vitro studies
Changes in the nerve at the site of injury begin almost immediately. Within hours after injury, the axons will sprout into multiple regenerating axons, 32, 33 and Schwann cells (SCs) play an important role in nerve regeneration at the site of injury. SC develop protein complexes that serve as physical conduits that guide axons to their targets. The rate of axon regeneration is limited by the extension of these SC processes 35 
SC
Artificial biohybrid transplant Transplanted canine SC contribute to the formation of bands of Bü ngner and are located in close vicinity to GAP-43 expressing regenerating nerve fibers. This provides first evidence that transplanted genetically modified SC do successfully integrate into the host tissue where they could actively contribute to the regeneration process. Wan et al. 36 Neurons and SC Co-culture subjected to electrical stimulation (ES)
The ES of the site of nerve injury potentiated axonal regrowth and myelin maturation during peripheral nerve regeneration. The myelination progress was mediated via enhanced brain-derived neurotrophic factor signals, which driving the promyelination effect on SCs at the onset of myelination. Liu et al. 37 
Matrix metalloproteinases (MMPs) inhibitor
MMPs inhibitor enhanced division of cultured primary SCs. The administration immediately after rat sciatic nerve crush and daily thereafter produced increased nerve regeneration and growth-associated expression. After MMP inhibition, myelin basic protein mRNA expression and active mitosis of myelin-forming SCs were reduced. Peng et al. Rho-kinase inhibitor, fasudil
RhoA/Rho-kinase as a molecular target to enhance axonal regeneration Amplitudes of distally evoked compound muscle action potentials are increased significantly faster after axonal injury in mice treated with fasudil compared with controls. Histological analysis shows that fasudil treatment increases the number of regenerating axons with large diameter.
Non-surgical therapies for peripheral nerve injury Table 2 Studies in animals (n ¼ 39).
Câ mara et al.
70
Rat sciatic nerve Low-intensity laser therapy (904 nm) The low-intensity laser therapy group showed an increased number of SC, myelinic axons with large diameter and neurons than the control with a significant level. Haastert-Talini et al.
55
Rat sciatic nerve Low-frequency electrical stimulation Combining low-frequency electrical stimulation to nerve autotransplantation, silicone tubes filled of SC or tubular grafts with fibroblast growth factor showed a high rate of nerve regeneration. Kosins et al. 85 Rat sciatic nerve Immunological demyelination Immunological demyelination enhanced regeneration in the peripheral nerve system. The axon count, axon density and nerve fiber diameter within the region of acute crush injury was improved. Regenerated axons partially derived from the proximal motor axons. Luria et al.
86
Rat sciatic nerve Glatiramer A single treatment with glatiramer acetate resulted in accelerated functional and histological recovery after sciatic nerve crush injury. The role of T-cell immunity in the mechanism of glatiramer acetate was suggested by the partial and late response found in the T-cell-deficient rats. Joung et al.
71
Rat sciatic nerve Neuregulin 1 Promoted nerve regeneration in the histology of axons, Schawnn cells and increased expression of neurofilaments, GAP43 and S100 in the distal stump. Sensory and motor functions were significantly improved in treated animals in behavioral tests. Yin et al.
120
Rat sciatic nerve Erythropoietin Increase in the axon diameter, myelin thickness and total number of nerve fibers as well as the degree of maturity of regenerated myelinated nerve fibers in comparison with those rats not treated with EPO. There was no significant difference in the motor function between the two groups at 4 weeks. Rat sciatic nerve AFS þ granulocyte-colony stimulating factor (G-CSF)
Crush injury-provoked inflammation was attenuated in groups receiving G-CSF but not in AFS only group. In transplanted AFS, marked apoptosis was detected and this event was reduced by G-CSF treatment.
Increased nerve myelination and improved motor function were observed in AFS transplanted, G-CSF administrated and AFS/G-CSF combined treatment groups. Significantly, the combined treatment showed the most beneficial effect. Pan et al.
80
Rat sciatic nerve Natto/AFS/Natto þ AFS Administration of Natto suppressed the inflammatory responses and correlated with decreased AFS and SC apoptosis. The combined therapy caused the most significantly beneficial effects. Lu et al. 57 Rat sciatic nerve ES The group receiving ES, especially at 1 mA had significantly shorter latency, larger amplitude, larger area of the evoked muscle action potentials and faster conduction velocity compared with the controls. However, ES at 4 mA provoked adverse responses to the function recovery of regenerated nerves in the kinematic gait analysis. ES appears to have a detrimental effect on the regeneration process. Wei et al.
100
Rat sciatic nerve Lumbricus extract For nerve function index value, for conduction velocity, for the number of regenerated myelinated nerve fibers, treatment group is higher than the control group at weeks 2 (3) and 6. Padilla-Martin et al.
99
Rat sciatic nerve Glycine intravenous Glycine was effective in the morphologic regeneration and functional recovery of the sciatic nerve postinjury in Wistar rats with 1 month administration.
Continued
Non-surgical therapies for peripheral nerve injury Rat sciatic nerve Electrical stimulation (ES) and exercise Groups that received acute ES and/or were forced to exercise in the treadmill showed higher levels of muscle reinnervation and increased numbers of regenerated myelinated axons when compared to control animals or animals that received chronic ES. The maintenance of activity helps to prevent the development of hyperreflexia. Elfar et al. 89 Rat sciatic nerve Erythropoietin The sciatic function index was 60% better in the erythropoietin-treated mice at 7 days postinjury (P , 0.05). Although the group that had been given the erythropoietin immediately postinjury showed the best enhancement of recovery, the timing of the administration of the drug was not critical. Histological analysis demonstrated enhanced erythropoietin-receptor positivity in the nerves that recovered fastest, suggesting that accelerated healing correlates with expression of the receptor in nerve tissue. Delaviz et al.
76
Rat sciatic nerve Olfactory ensheathing glia (olfactory mucosa transplant)
The total number of DiI-labeled motorneurones in the ventral horn (L4 -L6) and the sciatic function index scores were significantly higher in the group of rats that received olfactory mucosa rather than respiratory mucosa. Cá mara-Lemarroy et al.
87
Rat sciatic nerve crush injury
Celecoxib (COX-2 inhibitor)
Celecoxib had beneficial effects on sciatic function index, with a significantly better score on Day 7. Chabas et al. 98 
Rat peroneal nerve
Peroneal nerve autograft þ vitamin D2 Vitamin D2 significantly increased axogenesis and axon diameter, improved the responses of sensory neurons and induced a fast-to-slow fiber tpe transition of the Tibialis aterior muscle. Jankowski et al.
104
Mouse saphenous nerve Sox11 siRNA Analysis of Sox11 RNAi-injected nerves showed that regeneration of myelinated and unmyelinated axons was inhibited.
All neurons in ganglia of crushed nerves that were Sox11 immunopositive showed colabeling for the stress and injury-associated activating transcription factor 3.
Zuijdendorp et al.
105
Rat sciatic nerve Regenerating agents (OTR4120) adhesion tissues No significant difference in conduction capacity between the RGTA and the control group. The static footprint analysis demonstrates no improved or accelerated recovery pattern.
The mean pullout force of the RGTA group (67 + 9 g) was significantly (P , 0.001) lower than that of the control group (207 + 14 g). The RGTAs strongly reduce nerve adherence to surrounding tissue after nerve crush injury. Panseri et al.
82
Rat sciatic nerve Electrospun tubes (bioscaffolds) Electrospun tubes induced nervous regeneration and functional reconnection of the two severed sciatic nerve tracts. Myelination and collagen IV deposition have been detected in concurrence with regenerated fibers. Reinnervation of the target muscles in the majority of the treated animals. Rochkind et al.
68
Rat sciatic nerve Laser phototherapy Positive somatosensory-evoked potentials at 3 months: 70% laser group .40% non-irradiated rats.
More intense axonal growth. Grasso et al.
90
Rat sciatic nerve rHuEPO or darbepoetin alfa Darbepoetin alfa shortened the duration of peripheral nerve recovery' and facilitated recovery from the neurological and electrophysiological impairment following crush injury significantly better than rHuEPO. The administration of erythropoietin in its long-lasting recombinant forms affords significant neuroprotection in peripheral nerve injury models and may hold promise for future clinical applications. Hess et al.
84
Primates ulnar nerve Autografts, fresh allografts, cold-preserved allografts (CPA), CPA seeded with SCs Cytokine production in response to cold-preserved allografts and cold-preserved allografts seeded with autologous SCs was similar to that observed for autografts. SC-repopulated cold-preserved grafts demonstrated significantly enhanced fiber counts, nerve density and percentage nerve (P , 0.05) compared with unseeded cold-preserved grafts at 6 months after reconstruction. Zou et al. 103 
Mouse
Tissue plasminogen activator Tissue plasminogen activator increased the number of macrophages and induced MMP-9 expression at the injury site, coincident with reduced collagen scar formation and accelerated clearance of myelin and lipid debris after treatment. Kadoya et al. 93 Rat sciatic nerve Oxidized galectin-1 The recovery curves of toe spread in the test group showed a statistically significant improvement of functional recovery after Day 21 by the application of oxidized recombinant human galectin-1/Ox compared with the control group. This functional recovery was supported by histological analysis. Rovak et al. 74 
Rat peroneal nerves
Vascular endothelial growth factor (VEGF-165) Two-centimeter nerve gaps were created in rat peroneal nerves and repaired with either peripheral nerve autografts, acellular peripheral nerve isografts or VEGF-165-treated acellular peripheral nerve isografts. In the absence of any cellular elements, VEGF-impregnated acellular peripheral nerve grafts do not demonstrate enhanced axonal elongation, as noted by relatively few axons at the distal nerve graft coaptation site.
Continued
Non-surgical therapies for peripheral nerve injury Rat sciatic nerve Chitosan In 5-mm nerve defects, the quality of nerve regeneration was similar to that of the control group. For 10-mm nerve defect, nerve regeneration was inferior to that of the control group. Chitosan-collagen film degraded at 12 weeks postoperatively. Bannaga et al. 64 Rat sciatic nerve Magnetic stimulation (MS) Higher sciatic function index, toe spreading reflex, amplitude and velocity of MCAP and NCAP, mean axon count above the lesion for thick myelinated fibers (.6.5 mm), mean axon count above the lesion for thin myelinated fibers (2 -6.5 mm) for MS .control. Acetylcholine esterase examination showed that the MS could significantly increase the number of the motor neurons, but there was no significant difference in the number of the motor neurons between the treatment side and the normal side (P . 0.05). Mosahebi et al. 81 Rat sciatic nerve Allogenic vs. syngeneic SCs Allogeneic SCs were rejected by 6 weeks, whereas syngeneic SC could still be identified. Equally enhanced the axonal regeneration distance but the quantity of axons was greater using syngeneic SC. Allogenic SC did not induce deleterious immune response. SC continued to express phenotypic markers of non-myelination and these were highest in conduits with allogeneic SC. Young et al.
72
Rat sciatic nerve NGF and neurotrophin-3 (NT3) Neither NT3, nor NGF-treatment significantly enhanced motor recovery as examined by gait analysis. At the end of 12 weeks of behavioral testing, there was no difference in motor recovery. Regenerated sciatic nerves from NT3-treated animals had slightly more axons than control-or NGF-treated animals. Tariq et al.
107
Rat sciatic nerve Diethyldihio-carbamate (DEDC) Treatment of animals with DEDC caused a significant delay in functional recovery, which was accompanied by poor histological and electrophysiological outcome. Prooxidant effect of DEDC is quite evident from a significant decrease in vitamin E levels.
rather than by axonal growth. 34 For extended nerve defects, bridging with an autologous nerve transplant is the gold standard therapy, but has the disadvantage of donor-site morbidity. Natural or artificial nerve conduits could support nerve regeneration over longer distances and obviate the risk of rejection and immunosuppression. Schmitte et al. 35 described an artificial biohybrid nerve transplant, which combines a synthetic conduit with autologous SC genetically primed to express regeneration-promoting proteins. After the manipulation of the SC, they successfully integrated into the host tissue where they could actively contribute to the regeneration process. Wan et al. 36 co-cultured the neurons and the SC of a sciatic nerve of rats after a crush injury. The culture was subjected to 1 h of continuous electrical stimulation. A potentiated regrowth and myelin maturation was evident in the group receiving electrical stimulation than the controls. The myelination was mediated via enhanced brain-derived neurotrophic factor signals. 36 Other ways to modulate the SC signalling and mitosis could be through the action of the matrix metalloproteinases. 37 Liu et al. 37 tested the hypothesis that the administration of matrix metalloproteinases inhibitor stimulated mitosis in the SC and advanced nerve regeneration. The study 37 established novel roles for matrix metalloproteinases in peripheral nerve repair via control of SC mitosis, differentiation and myelin protein mRNA expression.
Other sources of transplantable cells to enhance nerve regeneration have been proposed. Skin-derived precursor cells are an easily accessible source of autologous stem cells with the ability to secrete bioactive neurotrophins, acting as functional SC. 38 In a rat sciatic nerve gap of 12 mm, after 4 weeks immunohistology showed survival of both cell types, and early regeneration in skin-derived precursor cells seeded grafts was comparable to those seeded with SCs. 38 Human umbilical cord-derived mesenchymal stromal cells were effective for axonal regeneration comparable to that of human SC based on histological criteria and functional recovery. 39 Immunohistochemistry and immunoelectron microscopy also demonstrated myelination of regenerated axons by human umbilical cord-derived mesenchymal stromal cells. 39 Wharton's jelly-derived mesenchymal stem cells have recently shown promising results, 40 being able to differentiate into SC in terms of morphologic features, phenotype and function.
Changes in the levels of neurotrophins within both the proximal and distal stump also occur. Neurotrophin 4/5 mRNA in the distal stump is increased, as well as nerve growth factor (NGF), brain-derived neurothrophic factor (BDNF) and glial-derived neurothrophic factor (GDNF). In sensory nerves, neuropeptides such a substance P decrease, whereas vasoactive intestinal peptide and cholecystikinin increase. 41 Magill et al. 42 evaluated the levels of GDNF using histomorphometry and muscle force and power testing after a rat sciatic nerve crush, and confirmed the increased levels at 2 weeks, but no differences with the controls at 6 weeks. When GDNF was encapsulated in a biodegradable protein polymeric composite, after 3 months of bridging, a 15-mm sciatic nerve gap of both substances acted synergistically. 43 NGF is secreted by SC after axotomy, 44, 45 but at 3 weeks its levels decrease. Different lag-time of pulse-released NGF within polycaprolactone conduits showed bioactivity of the NGF by neurite outgrowth of PC12 cells. 46 With a high concentration of the NGF within low crosslink controlled-release nerve conduits made it possible to bridge a 15 mm rat sciatic nerve defect. 46 Heat shock proteins and endothelin are upregulated after peripheral nerve injury. Heat shock proteins are important in neuroprotection after a variety of stresses or injuries, but their regulation has not been systematically studied in peripheral nerves. Using a tissue culture model for the sciatic nerve (PC12 cells), Klass et al. 47 found that endothelin treatment did not cause up-regulation of heat shock proteins.
After nerve transection, the distal segment undergoes a slow process of degeneration know as Wallerian degeneration. This process starts immediately after injury and involves myelin breakdown and proliferation of SC. These proliferating SC organize themselves into columns, and the regenerating axons associate with them by growing distally in between their basal membranes. RhoA, a key regulator of neurite elongation after nerve injury, is activated in motoneurons. Its effector, Rho-kinase, retards axon regeneration. Hiraga et al. 48 employed fasudil, a Rho-kinase inhibitor, finding an increased number of regenerating axons with large diameter, without suppressing the myelination of regenerating axons. Given these findings that benefit the maturity of axons, Rho-kinase could be a practical molecular target in peripheral neuropathies. 48 
Animal studies

Physical therapies
A peripheral nerve injury produces degeneration of the distal axon to the injury, retrograde degeneration of their corresponding neurons of the spinal cord, followed by a very slow regeneration. Recovery may eventually occur, but it is slow and frequently incomplete. The secondary effects of peripheral nerve injury are muscle wasting and a high incidence of pressure sores. Therefore, numerous attempts have been made to enhance and/or accelerate the recovery of injured peripheral nerves and decrease or prevent atrophy of the corresponding muscles. Electrical stimulation produces neurobiological effects, such as relieving pain in the region of head and face 49 and restoring movement and function in individuals with spinal cord injury. 50, 51 It can directly exert effects on regenerating neural tissues in a well-controlled experimental environment. 52 Low-frequency electrical stimulation holds promise to accelerate nerve regeneration after injury. 53 -55 However, a high frequency of electrical stimulation may increase failure of nerve regeneration. 56 Therefore, electrical stimulation could have a positive or negative impact on peripheral nerve regeneration depending on the current power of the electrical stimulus. 57 Electrical stimulation with testosterone propionate 58 has differential effects on gene expression, with electrical stimulation leading to early Non-surgical therapies for peripheral nerve injury British Medical Bulletin 2011;100 but transient upregulation. Also testosterone propionate produces late but steady increases in mRNA levels. In comparison to individual treatments, the combinatorial treatment strategy has the most enhanced effects on the transcriptional program activated following the injury. 58 The short-term application of low-frequency electrical stimulation of proximal peripheral nerve stumps prior to end-to-end coaptation or tubular bridging of small distances has been reported to increase preferential motor reinnervation and functional motor recovery in animal models and human patients undergoing carpal tunnel release surgery. 59 Haastert-Talini et al. 55 studied the effects of the low-frequency electrical stimulation on three different reconstruction approaches: nerve autotransplantation, silicone tubes filled with SC, and tubular grafts containing fibroblast growth factor. In all instances, the combination showed a high rate of nerve regeneration, and in the nerve autotransplantation and the tubular graft groups, the construct functionally reconnected to the target muscle.
With electrical stimulation and exercice, 60 rats that received acute electrical stimulation and/or were forced to exercise on the treadmill had higher levels of muscle reinnervation and increased numbers of regenerated myelinated axons when compared with control animals or animals that received chronic electrical stimulation. Combining electrical stimulation after suture repair with treadmill training significantly improved muscle reinnervation during the initial phase. The facilitation of the monosynaptic H reflex in the injured limb was reduced in all treated groups, suggesting that maintenance of physical activity helps to prevent the development of hyperreflexia.
In veterinary medicine, electrodiagnostic evaluation of peripheral nerve disorders is mostly achieved by electrical stimulation of peripheral nerves, 61 but little is known about magnetic nerve stimulation in animals. With electrical stimulation, current is passed into the body via needle electrodes. In magnetic stimulation a brief magnetic pulse induces a current in conductive tissues. 62 Magnetic stimulation provides a non-invasive and almost painless alternative to electrical nerve stimulation. The disadvantages of the technique are (i) problems in obtaining a consistent supramaximal response as compared to the response obtained after electrical stimulation and (ii) defining the exact site of localisation. 63 Magnetic stimulation 64 could enhance functional recovery, and has a considerable effect in the management of the peripheral nerve injury. However, there was a non-significant trend of increasing the number of motor neurons (P . 0.05) in rats after a crushed sciatic nerve. 64 Low-power laser irradiation (laser phototherapy) enhances and/or accelerates the recovery of injured peripheral nerves, and decreases or prevents atrophy of the corresponding muscles. 65 Although a pioneering report on the effects of laser phototherapy on the regeneration of traumatically injured peripheral nerves was published in the late 1970s, 66 only since the late 1980s scientific interest was shown in this therapeutic approach for neural rehabilitation. 67, 59 Laser phototherapy was applied to rat-denervated muscle to estimate biochemical stimulus on cellular and tissue levels, and on rat sciatic nerve model after crush injury, direct or side-to-end anastomosis and neurotube reconstruction. 68 Nerve cells growth and axonal sprouting were investigated in embryonic rat brain cultures. Animal outcomes proved the basis for future human randomized control trials measuring the effectiveness of 780-nm laser phototherapy. 69 A recent study analyzed the influence of the low-intensity laser therapy in regeneration of the sciatic nerve in rats. 70 Although the wavelength of the laser used in that investigation, 904 nm, differed from the study of Rochkind et al., 69 they also found positive effects in the regeneration of the injury nerve.
Growth factors
Schawnn cells play an important role in axon regeneration. The rate of axon regeneration is limited by the extension of these SC processes rather than by axonal growth. 34 Joung et al., 71 based on the hypothesis that Neuregulin 1 and epidermal growth factor receptor signaling pathways control SC during axonal regeneration, investigated whether a persistent supply of recombinant Neuregulin 1 to the injury site could improve axonal growth and recovery of sensory and motor functions in rats during nerve regeneration. Transduction of the concentrated form of Neuregulin 1 into an axotomy model of sciatic nerve damage induced an effective promotion of nerve regeneration, as shown by histological features of the axons and SC, as well as increased expression of neurofilaments, growth associated protein-43 (GAP-43) and S100 in the distal stump of the injury site. This result was consistent with longer axon lengths and thicker calibers observed in the treated animals. Furthermore, sensory and motor functions were significantly improved in treated animals when evaluated by a behavioral test. 71 Changes in the levels of neurotrophins within both the proximal and distal stump take place after a nerve injury. NGF is secreted by SC after axotomy, 44, 45 but at 3 weeks its levels decrease. Chang 46 demonstrated in vitro that a high concentration of NGF within low crosslink controlled-release nerve conduits made possible to bridge a 15 mm rat sciatic nerve defect. 46 However, a continuous supply of NGF and neurotrophin-3 did not improve long-lasting anatomical or functional outcomes in rats 12 weeks after sciatic nerve transection. 72 Some neurotrophic factors decline with age, and the insulin-like growth factor 1 (IGF-1) is one of them. 73 Apel et al. 73 showed that in young and aged rats, the continuous deliver of IGF-1 to the site of nerve repair, compared with saline, significantly improved axon number, diameter, density, myelination and Schwann cell activity and preserved the morphology of the postsynaptic neuromuscular junction. Growth factors can be applied locally or added to grafts. In a 2 cm peroneal nerve gap in rats, Rovak et al. 74 compared the effects of a peripheral nerve autograft, an acellular peripheral nerve isograft and an acellular peripheral nerve isografts supplemented with human recombinant vascular endothelial growth factor (VEGF-165). Even though nerve autografting is still the gold standard for nerve gap repair, shorter defects up to 3 cm can be repaired with natural or artificial conduits. 5 At the proximal nerve gap coaptation site, there was a statistically significant (P , 0.05) increase in the total number of axons and percent neural tissue in the VEGF-treated acellular nerve graft group, compared with the acellular peripheral nerve isograft and autograft groups. At the distal coaptation site, the total number of axons and percent neural tissue was significantly less than the autograft group. Rovak et al. 74 concluded that, in the absence of any cellular elements, the vascular endothelial growth factor did not enhanced axonal elongation.
Cell sources
Injuries to peripheral nerves result in progressive skeletal muscle atrophy and poor functional recovery. Transplanting neural stem cells into peripheral nerves can induce differentiation into neurons and delay muscle atrophy. However, the mechanisms are not clear. 75 Gu et al. 75 demonstrated in rats that fetal neural stem cells transplanted into peripheral nerves could differentiate into neurons and form functional neuromuscular junctions with in denervated muscle. This could be beneficial for the treatment of muscle atrophy after peripheral nerve injury.
Based on the hypothesis that olfactory ensheathing glia has neuroprotective effects in spinal cord injury, Delaviz et al. 76 tested the possible beneficial results in a transected sciatic nerve. The rats receiving olfactory mucosa transplantation showed better outcomes in functional recovery and axonal regeneration than those who received respiratory mucosa. Radtke et al. 77 supported the hypothesis that the transplantation of myeling-forming cells, such as SCs or olfactory ensheathing cells were capable of bridging the repair site by establishing an environment permissive to axonal regeneration. However, the use of olfactory ensheathing cells has only been proved in animals and the evidence in peripheral nervous system is experimental. 77 Another cell source used in animal studies has been amniotic fluid mesenchymal stem cells. As the pro-inflammatory environment of an injured tissue could lead amniotic fluid mesenchymal stem cells to apoptosis, Pan et al. 78 administered hyperbaric oxygen to a rat-crushed sciatic nerve that was embedded in a fibrin glue rich of amniotic fluid mesenchymal stem cells. The authors 78 evaluated the beneficial effect of hyperbaric oxygen on the transplanted amniotic fluid mesenchymal stem cells. Crush injury resulted in production of inflammatory cytokines, deposits of inflammatory cytokines and associated macrophage migration chemokines that were attenuated in groups receiving hyperbaric oxygen but not in the amniotic fluid mesenchymal stem cells-only group. Amniotic fluid mesenchymal stem cells transplant increased nerve myelination and improved motor function. Significantly, the amniotic fluid mesenchymal stem cells/hyperbaric oxygen combined treatment showed the most beneficial effect. 78 Amniotic fluid mesenchymal stem cells harbour the potential to improve peripheral nerve injury by inherited neurotrophic factor secretion, but present the drawback of short-term survival after transplantation. Pan et al. 79 evaluated whether granulocyte-colony stimulating factor (G-CSF), given its anti-inflammatory and anti-apoptotic affects, could augment the neuroprotective properties of transplanted amniotic fluid mesenchymal stem cells against peripheral nerve injury. The combined treatment showed the most beneficial effect. 79 Another way of attenuating inflammatory cytokines and prevent the apoptosis of the transplanted stem cells in a sciatic nerve crush injury is administering fermented soybeans (Natto) to transplanted amniotic fluid mesenchymal stem cells. 80 The immediate availability of autologous SC in the reconstruction of a peripheral nerve defect remains a challenge. If allogeneic SC could equally enhance the axonal regeneration without deleterious immune response, the transplantation of syngeneic SC would compensate the longer preparation time in culture of the autologous SC. 81 The results in rats are encouraging, but further clinical studies are needed.
Bioscaffolds
Consistent loss of nervous tissue in PNI may impair movements of patient by interrupting their motor-sensory pathways. In the last few decades, tissue engineering has opened the door to new approaches. However, most of them make use of rigid channel guides that may cause cell loss from the lack of physiological local stresses exerted over the nervous tissue during patient's movement. Electrospun tubes 82 are promising scaffolds for functional nervous regeneration. They can be knitted in meshes and various frames depending on the cytoarchitecture of the tissue to be regenerated. The versatility of this technique gives room for further scaffold improvements, such as tuning the mechanical properties of the tubular structure or providing biomimetic Non-surgical therapies for peripheral nerve injury British Medical Bulletin 2011;100 functionalization. Moreover, these guidance conduits can be loaded with various fillers, including collagen, fibrin or self-assembling peptide gels or loaded with neurotrophic factors and seeded with cells. Electrospun scaffolds can also be synthesized in different microarchitectures to regenerate lesions in other tissues such as skin and bone. 82 Based on tissue-engineering technology, Rochkind et al. 83 described a biodegradable composite neurotube containing viscous gel with survival factors, neuroprotective agents and SCs. The bioscaffold served as a regenerative environment for repair.
An option for nerve gaps beyond 3 cm could be the cold-preserved allografts seeded with autologous SCs. 84 Hess et al. 84 used autologous tissue in the reconstruction of an extensive ulnar nerve injury in primates as a safe and effective alternative.
Other proteins/molecules
Based on the physiology of nerve recovery after an injury, Kosins et al. 85 caused an experimental inmmunological demyelination in 10 sciatic rat nerves. An epineural injection of complement proteins plus antibodies to galactocerebroside resulted in demyelination, but was followed by a faster and improved SC remyelination compared with the control group. The regenerated axons partially derived from the proximal motor axons. 85 The delivery of factors to the site of injury and their dosage regimen have been major problems in this field of research. Neuroprotective therapy is aimed at boosting the beneficial autoimmune response to injury-associated self-antigens. Immune cells play a role in the regulation of motor neuron survival after a peripheral nerve injury, and the antigen glatiramer acetate is known to affect T-cell immunity on peripheral nerve regeneration. 86 Based on this hypothesis, Luria et al.
86
found that a single treatment with glatiramer acetate resulted in accelerated functional and histological recovery after sciatic nerve crush injury. Related to the inflammatory response, the cyclooxygenase-2 (COX-2) is strongly upregulated around the nerve injury site. After an experimental study in rats, the anti-inflammatory drug celecoxib is suggested to be considered in the treatment of PNI. 87 Considering that cholesterol and lipids are needed for reconstructing myelin sheaths and axon extension, Li et al. 88 supported the hypothesis that supplementation with exogenous apolipoprotein (apoE) mimetics could be a strategy for restoring lost functional and structural elements following nerve crush. The postinjury treatment with apoE-mimetic peptide promoted axonal regrowth after 2 weeks of treatment compared with the control group. The morphometric analysis showed an increased thickness of myelin sheaths, an increased clearance of myelin debris and the markers of axon regeneration and remyelination. 88 Erythropoietin may have neuroprotective, and perhaps have neurotrophic roles 89, 90 in acute sciatic nerve crush injury. This protective effect could have clinical relevance, especially since it was detectable even when erythropoietin had been administered up to 1 week after injury. 89 Still, darbepoetin alfa, the long-lasting derivate of recombinant human erythropoietin (rHuEPO), showed faster recovery of neurological function with weekly administration than the rHuEPO treatment. 90 Many experiments have been undertaken using different factors to facilitate better or faster nerve stump growth: NGF, platelet growth factor, hyaluronic acid, leukemic inhibiting factor and GABA 91, 92 oxidized galectin-1. 93 Another organic molecule implicated in nervous system development and repair is the alpha 2.8 Polysialic acid, a carbohydrate attached to the glycoprotein backbone of the neural cell adhesion molecule. The application of functional polysialic acid considerably improved the remyelination of regenerated axons distal to the injury site, indicating that effects on SCs in the denervated nerve may underlie the functional effects seen in motor recovery. 94 Valproic acid 95 enhanced recovery by promoting neurite outgrowth, activating kinase pathway and increasing growth cone in neuroblastoma cells.
Acetyl-L-carnitine prevented neuronal loss by increasing their aerobic capacity. 96, 97 Vitamin D2 stimulated axon regeneration when added to a nerve autograft in rats. 98 Glycine is an inhibitory neurotransmitter in the brain stem and spinal cord, and it also plays a critical role as a modulator of NMDA receptors. 99 After the administration of glycine, a damaged nerve showed similar characteristics to a healthy nerve.
In traditional Chinese medicine, Lumbricus has been used to promote nerve function for hundreds of years, based on the idea that earthworms regenerated amputated parts of their body if the nervous system was intact. 100 Lumbricus extract promoted the regeneration of PNI in rats, with a higher nerve function index value, conduction velocity and number of regenerated myelinated nerve fibers than the control group. 100 In rats, the aqueous extract of Radix Hedysari Prescription is beneficial, suggesting the potential clinical application of Hedysari polysaccharides for the treatment of peripheral nerve injury in humans. 101 The oral intake of the Japanese natto (fermented soybean) had the potential to augment regeneration in peripheral nerve injury, given its similar biological activity to tissue-type plasminogen activator (t-PA) that mediated by the clearance of fibrin and decreased production of TNF-alpha. 102 Acting directly in the photolytic cascade by the administration of exogenous tPA, Zou et al. 103 promoted axonal regeneration and remyelination prevention of collagen scar formation.
Other animal studies focus on the role of transcription factors, such as Sox11, in the functional and anatomical recovery after a PNI. 104 The application of polymers as regenerating agents (OTR4120) mimic stabilizing and protective properties, and reduce nerve adherence to surrounding tissue after nerve crush injury. 105 BRX-220 is a co-inducer of heat shock proteins that promoted restoration of morphological and functional properties in the sensory system. 106 Although most studies are based on products that hypothetically enhance the process of reinervation, there are fewer that did not show any satisfactory results.
Diethyldithiocarbamate is known for its multiplicity of action that exerts both pro-and antioxidant effects. In PNI, the exposure to diethyldithiocarbamate adversely affected recovery. 107 To bridge the nerve defects, a chitosan-collagen film has also been used. 108 It did not show any superiority to the control end-to-end anastomosis, and its degradation at 12 weeks made it useless.
Human studies
Physical therapies
Low-power laser irradiation (laser phototherapy) alters nerve cell activity, inducing upregulation of several neurotrophic growth factors and extracellular matrix proteins, which support neurite outgrowth. 109 A possible molecular explanation was provided by demonstrating an increase in GAP-43 immunoreactivity in the early stages of rat sciatic nerve regeneration after phototherapy. 110 Snyder et al. 111 showed that phototherapy upregulates calcitonin gene-related peptide mRNA expression in facial motor nuclei after axotomy. By altering the intensity or temporal pattern of injury-induced CGRP expression, phototherapy could optimize the rate of regeneration and target innervations and neuronal survival of axotomized neurons. 111 In cell cultures, laser irradiation accelerates migration, nerve cell growth and fiber sprouting (Rochkind et al. 59 ). In denervated muscles, animal studies suggest (Rochkind et al. 59 ) that the function of denervated muscles can be partially preserved by temporary prevention of denervation-induced biochemical changes. The function of denervated muscles could be restored to a very substantial degree by laser treatment initiated at the earliest possible stage postinjury. 65 In a pilot, clinical, double-blind, placebo-controlled randomized study in patients with incomplete long-term peripheral nerve injury, 780 nm laser irradiation progressively improve peripheral nerve function, which lead to significant functional recovery (P ¼ 0.0001). 69 No statistically significant difference was found in sensory function. Electrophysiological analysis also showed statistically significant improvement in recruitment of voluntary muscle activity in the laserirradiated group (P ¼ 0.006), compared with the placebo group. 69 In peripheral nerve injury, laser phototherapy has shown an immediate protective effect. It maintains functional activity of the injured nerve for a long period, decreases scar tissue formation at the injury site, decreases degeneration in corresponding motor neurons of the spinal cord and significantly increases axonal growth and myelinization. 65 Gordon et al.
14 has also shown promising results in animal models using low-frequency electrical stimulation for only 1 h, as it significantly accelerated regeneration through speeding of axon growth across the injury site. They carried out a randomized controlled trial in patients who had experienced substantial axonal loss in the median nerve from severe compression in the carpal tunnel. They demonstrated that effects similar to those observed in animal studies could also be attained in humans.
14 Acupunture has been a traditional Chinese practice of stimulating nerve regeneration. Hao et al. 112 performed a case -control study in patients suffering from PNI in different locations. Fifty-four patients were treated by electric acupuncture and compared with 54 controls who received supportive medication. The changes after treatment were observed chiefly by electromyography, while sensory and motor improvements were also recorded as auxiliary indicators. Acupunture was effective in 50 patients (92.6%) in contrast to the 30 controls (55.6%). The patients in the acupuncture group were significantly better than those in the control group; nerve injuries should be treated as early as possible; the radial nerve and the common peroneal nerve recovered faster than others; cases not surgically explored recovered faster than those that were, and patients with prompt propagation of the needling sensation recovered significantly faster than those with slow propagation.
The relationship of proprioceptive (kinesthetic) feedback to motor physiology lead Brudny et al. 18 to perform a prospective case study forHowever, we did not include this study given the heterogeneous group over all feedback therapy.
Discussion
The strategies for nerve regeneration include a variety of surgical procedures, grafting, new biologically based technologies and tissue engineering. 10 In the management of nerve injuries, most of the published studies focus on bridging methods and nerve conduits. 5 Conservative therapies aim to control neuropathic pain after nerve tissue damage.
Research has focused on conservative therapies to enhance nerve regeneration. Few studies have been performed 59, 69, 14, 112 in humans. All experiments with physical therapy modalities, and their effectiveness are not proved. Laser phototherapy has been studied in relative depth, but the studies involve small cohorts of patients, different nerves and etiology of injury. 113, 59 The indications for laser phototherapy are disparate, being used in multiple dermatological pathologies, in cosmetics, and in lung and airway problems. 114, 115 It is a non-invasive treatment, with minimal side effects, 116 but high-quality studies are needed to assess its role in this field.
Most experiments are performed in animal models. Physical therapies, growth factors, cell sources and some proteins intervene at the lesion site, since the location is usually promptly available at the time of nerve repair. An advantage of animal models is the opportunity to perform controlled experiments, but the therapies used in each study have been only compared with a control group and not against each other. It is difficult to measure superiority given the lack of a standard design: structuring the samples, animal model, type of injury, time of recovery; and also a lack of a standard reporting. Although each of the hypotheses is proved in animals, translation to clinical practice in humans is missing.
In vitro investigations concentrate on genetically modified cell sources 35, 39, 40 and neurotrophic factors 42, 43, 46 to bridge extensive nerve defects. They also study the endogenous response to nerve injury 47, 37 and the mechanisms of cell differentiation to provide a more accessible source of nerve cells, 38 and molecular targets to enhance axonal regeneration. 48 In vitro studies are helpful to understand the molecular pathways that follow nerve damage and localize targets as potential neuroprotectants. However, their evidence is still poor, their results are not reliable and their clinical application is limited.
Other reviews on PNI management are mostly based on experiments in animals, or in vitro and usually focus on specific areas of research: new sources of neural stem cells, 117 new tissue engineering approaches 118 and neuropathic pain management. 119 This systematic review provides a comprehensive view of the non-surgical modalities investigated to date in the field of PNI, reporting evidence from in vitro, animals and human studies.
Many modalities have been proposed to promote nerve healing and restore function. Despite this, essentially none has been actually translated into clinical practice. PNI is still an unsolved issue with a marked impact on everyday life of patients, and economic relevance to society. There is a wide field of research to deepen, and future quality clinical studies are needed to provide acceptable scientific evidence.
